Ambrx Biopharma Correlations
| AMAMDelisted Stock | USD 15.73 0.71 4.73% |
The current 90-days correlation between Ambrx Biopharma American and Day One Biopharmaceuticals is 0.16 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ambrx Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ambrx Biopharma American moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Ambrx Biopharma Correlation With Market
Good diversification
The correlation between Ambrx Biopharma American and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ambrx Biopharma American and DJI in the same portfolio, assuming nothing else is changed.
Ambrx |
Moving together with Ambrx Stock
| 0.74 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.78 | DIS | Walt Disney | PairCorr |
| 0.8 | AXP | American Express Earnings Call Tomorrow | PairCorr |
Moving against Ambrx Stock
| 0.85 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.75 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.7 | PTAIY | Astra International Tbk | PairCorr |
| 0.69 | PTITF | PT Indosat Tbk | PairCorr |
| 0.69 | KO | Coca Cola Fiscal Year End 11th of February 2025 | PairCorr |
| 0.67 | XOM | Exxon Mobil Corp Earnings Call Next Week | PairCorr |
| 0.65 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.61 | HPQ | HP Inc | PairCorr |
| 0.55 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.52 | PTAIF | PT Astra International | PairCorr |
| 0.48 | INTC | Intel Aggressive Push | PairCorr |
| 0.42 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.38 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.36 | TRV | The Travelers Companies | PairCorr |
| 0.35 | VZ | Verizon Communications Aggressive Push | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ambrx Stock performing well and Ambrx Biopharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ambrx Biopharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IMMX | 4.66 | 0.66 | 0.12 | 8.46 | 4.66 | 11.44 | 33.17 | |||
| CNSP | 4.54 | (0.02) | 0.00 | 0.05 | 0.00 | 10.00 | 39.29 | |||
| EFTR | 7.57 | (4.62) | 0.00 | (2.04) | 0.00 | 8.70 | 88.91 | |||
| NAVB | 6.04 | (1.10) | 0.00 | 7.04 | 0.00 | 12.50 | 40.40 | |||
| SONN | 5.10 | (1.12) | 0.00 | (101.87) | 0.00 | 9.59 | 37.58 | |||
| CWBR | 7.34 | 2.47 | 0.34 | (5.93) | 5.34 | 5.73 | 250.97 | |||
| ENVB | 4.00 | (0.38) | 0.00 | 0.43 | 0.00 | 9.09 | 36.00 | |||
| ELEV | 5.22 | 0.49 | 0.08 | 0.70 | 5.53 | 10.77 | 40.61 | |||
| HEPA | 6.10 | (1.46) | 0.00 | 1.68 | 0.00 | 9.33 | 62.53 | |||
| ZURA | 4.53 | (1.08) | 0.00 | 1.13 | 0.00 | 9.21 | 26.70 |
View Ambrx Biopharma Related Equities
| Risk & Return | Correlation |
Ambrx Biopharma Corporate Management
| Jared Kelly | General VP | Profile | |
| Xiao Le | Director | Profile | |
| Robert Azzara | Vice Capital | Profile | |
| Xiaowei Chang | Director | Profile | |
| Katrin Rupalla | Independent Director | Profile |
Still Interested in Ambrx Biopharma American?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.